Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Stephanie Dakin was awarded the prize for best scientific oral presentation and DPhil student Roxanna Abhari received the prize for best scientific poster, at the 4th International Scientific Tendinopathy Symposium (ISTS) in Cape Town.

The Symposium is a highly acclaimed clinical and scientific meeting for everything tendon related, with this year's theme being 'Today's research, tomorrow's translation'.

Arthritis Research UK Fellow Dr Dakin said: 'I'm delighted to have been awarded the ISTS prize for best scientific oral presentation for our work on 'Persistence of tendon inflammation: a leading role for the stroma?' and am very grateful to the support of the Carr research team for enabling us to perform this study. The findings from this work emphasise the important contribution of tendon cells to the development of chronic inflammation and recurrent disease'.

Roxanna presented work on the "Development and optimization of an electrospun material with potential for use in rotator cuff tendon repair", where she showed that heat treatment can be used to tailor the degradation rate of electrospun material to a clinically relevant profile for tendon repair. Her future work will aim to better match the degradation of the implant and gradual loss of mechanical properties with the new matrix deposition within the structure.

Similar stories

New children’s orthopaedic hospital opens in Zimbabwe

Main

A new children’s orthopaedic hospital in Bulawayo that will treat children across Zimbabwe who are living with musculoskeletal impairments has opened today.

Professor Katja Simon elected to the Academy of Medical Sciences

Awards Kennedy Main

Professor of Immunology Katja Simon has been elected as a Fellow of the Academy of Medical Sciences.

3,400 different medicines used globally to treat COVID-19

Main Statistics and epidemiology

Insufficient data, and misleading recommendations led to significant early heterogeneity in global COVID-19 patient management, according to recent BMJ study

Clinical trial finds Azithromycin has no benefit against COVID-19

Main OCTRU

A clinical trial by University of Oxford researchers has confirmed that the antibiotic azithromycin has no clinical benefit in people with moderate COVID-19.

Study reveals the three most important aspects of care for hip fractures

Hip Main OCTRU Research Trauma

Older patients with hip fractures recover better if they receive treatment under the supervision of both a surgeon and a specialist in elderly care; are checked to avoid future falls; and are assessed for memory problems.

Major ERC funding awarded to Professor Michael Dustin

Awards Kennedy Main

Professor Michael Dustin and an international team of collaborators have been awarded a €10M grant from the European Research Council (ERC) to develop a new biotechnology around supramolecular attack particles (SMAPs) engineered to kill cancer cells.